Literature DB >> 25589353

[Histological spectrum of malignant melanoma].

T Brenn1.   

Abstract

The diagnosis of melanocytic tumors is one of the most problematic areas in dermatology and diagnostic pathology. Melanoma is a malignant melanocytic tumor and the risk for metastasis and associated mortality is mainly dependent on tumor thickness and depth of invasion. Early recognition and correct diagnosis is therefore important for successful and effective treatment. The correct diagnosis of melanoma is, however, challenging due to the wide morphological spectrum. Historically, the disease was subdivided into superficial spreading, nodular, lentigo maligna and acral lentiginous melanoma but many more subtypes have subsequently been added. Some of these melanoma variants also show differences relating to the genetic background, clinical presentation, prognosis and treatment and may be associated with a specific differential diagnosis. In this article four of these melanoma variants, desmoplastic melanoma, nevoid melanoma, malignant blue nevus and pigment synthesizing melanoma will be discussed in more detail.

Entities:  

Mesh:

Year:  2015        PMID: 25589353     DOI: 10.1007/s00292-014-2001-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  20 in total

1.  Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma).

Authors:  J Conley; R Lattes; W Orr
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

2.  Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.

Authors:  Klaus J Busam; Hui Zhao; Daniel G Coit; Derya Kucukgol; Achim A Jungbluth; Jennifer Nobrega; Agnes Viale
Journal:  J Invest Dermatol       Date:  2005-02       Impact factor: 8.551

3.  Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.

Authors:  Pedram Gerami; Beth Beilfuss; Zahra Haghighat; Yuaquin Fang; Suresh Jhanwar; Klaus J Busam
Journal:  J Cutan Pathol       Date:  2011-04       Impact factor: 1.587

4.  Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up.

Authors:  Rajni V Mandal; Rajmohan Murali; Kurt F Lundquist; Bruce D Ragsdale; Peter Heenan; Stanley W McCarthy; Martin C Mihm; Richard A Scolyer; Artur Zembowicz
Journal:  Am J Surg Pathol       Date:  2009-12       Impact factor: 6.394

5.  Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution.

Authors:  M W Ludgate; D R Fullen; J Lee; R Rees; M S Sabel; S L Wong; T M Johnson
Journal:  Br J Dermatol       Date:  2009-04-30       Impact factor: 9.302

6.  Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases.

Authors:  K Blessing; A T Evans; A al-Nafussi
Journal:  Histopathology       Date:  1993-11       Impact factor: 5.087

7.  So-called "malignant blue nevus": a clinicopathologic study of 23 patients.

Authors:  Richard C W Martin; Rajmohan Murali; Richard A Scolyer; Patrick Fitzgerald; Marjorie H Colman; John F Thompson
Journal:  Cancer       Date:  2009-07-01       Impact factor: 6.860

8.  Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.

Authors:  Artur Zembowicz; J Aidan Carney; Martin C Mihm
Journal:  Am J Surg Pathol       Date:  2004-01       Impact factor: 6.394

Review 9.  Desmoplastic melanoma: a review.

Authors:  Lucy L Chen; Natalia Jaimes; Christopher A Barker; Klaus J Busam; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2012-12-23       Impact factor: 11.527

10.  Nevoid malignant melanoma.

Authors:  C Schmoeckel; C E Castro; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

View more
  3 in total

1.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

Review 2.  [Diagnostics of malignant melanoma of the skin : Recommendations of the current S3 guidelines on histology and molecular pathology].

Authors:  C Rose
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

3.  Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer.

Authors:  Mark Kriegsmann; Katharina Kriegsmann; Alexander Harms; Rémi Longuespée; Christiane Zgorzelski; Jonas Leichsenring; Thomas Muley; Hauke Winter; Daniel Kazdal; Benjamin Goeppert; Arne Warth
Journal:  Diagn Pathol       Date:  2018-09-11       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.